» Articles » PMID: 36230699

Role of the Hedgehog Pathway and CAXII in Controlling Melanoma Cell Migration and Invasion in Hypoxia

Overview
Journal Cancers (Basel)
Publisher MDPI
Specialty Oncology
Date 2022 Oct 14
PMID 36230699
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Malignant melanoma is the leading cause of death among skin cancer patients due to its tendency to metastasize. Alterations at the molecular level are often evident, which is why melanoma biology has garnered increasing interest. The hedgehog (Hh) pathway, which is essential for embryonic development, is aberrantly re-activated in melanoma and may represent a promising therapeutic target. In addition, carbonic anhydrase XII (CAXII) represents a poor prognostic target for hypoxic tumors, such as melanoma, and is involved in cell migration. Thus, we decided to investigate whether and how the Hh pathway and CAXII may control melanoma cell migration and invasiveness.

Methods: The migratory and invasive capabilities of SK-MEL-28 and A375 cell lines, either un-transfected or transiently transfected with Smoothened (SMO), GLI1, or CAXII siRNA, were studied under normoxic or hypoxic conditions.

Results: For the first time, we showed that SMO and GLI1 silencing resulted in the downregulation of CAXII expression in both moderately and highly invasive melanoma cells under hypoxia. The Hh pathway as well as CAXII inhibition by siRNA resulted in impaired malignant melanoma migration and invasion.

Conclusion: Our results suggest that CAXII and the Hh pathway are relevant in melanoma invasion and may be novel and promising therapeutical targets for melanoma clinical management.

Citing Articles

The roles of cancer stem cells and therapeutic implications in melanoma.

Mu X, Zhou Y, Yu Y, Zhang M, Liu J Front Immunol. 2024; 15:1486680.

PMID: 39611156 PMC: 11602477. DOI: 10.3389/fimmu.2024.1486680.


Hedgehog Pathway Inhibition by Novel Small Molecules Impairs Melanoma Cell Migration and Invasion under Hypoxia.

Falsini A, Giuntini G, Mori M, Ghirga F, Quaglio D, Cucinotta A Pharmaceuticals (Basel). 2024; 17(2).

PMID: 38399442 PMC: 10891729. DOI: 10.3390/ph17020227.

References
1.
Buart S, Terry S, Noman M, Lanoy E, Boutros C, Fogel P . Transcriptional response to hypoxic stress in melanoma and prognostic potential of GBE1 and BNIP3. Oncotarget. 2018; 8(65):108786-108801. PMC: 5752481. DOI: 10.18632/oncotarget.22150. View

2.
Gatenby R, Gillies R . Why do cancers have high aerobic glycolysis?. Nat Rev Cancer. 2004; 4(11):891-9. DOI: 10.1038/nrc1478. View

3.
Michaylira C, Nakagawa H . Hypoxic microenvironment as a cradle for melanoma development and progression. Cancer Biol Ther. 2006; 5(5):476-9. DOI: 10.4161/cbt.5.5.2749. View

4.
Scolyer R, Long G, Thompson J . Evolving concepts in melanoma classification and their relevance to multidisciplinary melanoma patient care. Mol Oncol. 2011; 5(2):124-36. PMC: 5528281. DOI: 10.1016/j.molonc.2011.03.002. View

5.
Livak K, Marmaro J, Todd J . Towards fully automated genome-wide polymorphism screening. Nat Genet. 1995; 9(4):341-2. DOI: 10.1038/ng0495-341. View